Changes in serum levels of Th1/Th2 cytokines in HBeAg-positive pregnant women with HBV infection after telbivu-dine treatment

黄鸿菲,何登明,吴全新,李茂仕,朱鹏,王宇明

DOI: https://doi.org/10.3969/j.issn.1001-5256.2014.06.011

2014-01-01

Abstract:Objective To evaluate the changes in serum levels of Th1/Th2 cytokines in pregnant women with chronic hepatitis B virus (HBV)infection after telbivudine treatment and to investigate the immune mechanism by which telbivudine blocks the mother-to-infant transmission of HBV.Methods Fifty-four HBeAg-positive pregnant women with chronic HBV infection were enrolled from April 2008 to September 2012,and they were divided into two groups based on their alanine aminotransferase (ALT)levels:immune active group (n=18)and immune tolerant group (n=36).Telbivudine was administrated at a dose of 600 mg per day during the second or third trimester. Before treatment and prior to delivery,the serum levels of ALT,total bilirubin (TBil),HBV DNA,and HBV markers were routinely meas-ured,and the levels of Th1 cytokines (interleukin-2 (IL-2),interferon -γ(IFNγ))and Th2 cytokines (interleukin-4 (IL-4),in-terleukin-6 (IL-6))were determined by enzyme-linked immunosorbent assay.SPSS 18.0 was used for statistical analysis.Results After treatment,HBV DNA level was reduced significantly (P<0.01),while there were no significant changes in serum ALT and TBil and no HBeAg seroconversion.Compared with the healthy population,before treatment and prior to delivery,both treatment groups showed high-er expression of IL-2 (healthy control <4 pg/ml)and IFNγ(healthy control <15 pg/ml)but lower expression of IL-4 (healthy control <10 pg/ml)and IL-6 (healthy control<5 pg/ml).Furthermore,there were no significant differences in IL-2,IFNγ,IL-4,and IL-6 levels between the two groups (P>0.01).Prior to delivery,IL-4 level was elevated in immune active group (P=0.014),but within the limits of normal range,while IL-2,IFNγ,and IL-6 levels showed no significant changes (P=0.182,0.259,and 0.710,respective-ly);the levels of IL-2,IFNγ,IL-4,and IL-6 in immune tolerant group showed no significant changes (P=0.651,0.839,0.650, and 0.542,respectively).Conclusion Th1 cytokines are highly expressed while Th2 cytokines are lowly expressed in the second or third trimester among HBV-infected pregnant women.Short-term telbivudine treatment has limited influence on Th1/Th2 balance in HBV-in-fected pregnant women,indicating that other mechanisms might be recruited for interfering with the mother-infant transmission of HBV.